Clinical Trials Browser

Phase 2 × Terminated × Leukemia, Lymphoid × Clear all

Leukemia, Leukemia, Lymphoid, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04155840 2022-04-11

Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2 Terminated

1 enrolled 6 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00006092 2012-09-26

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia

Phase 2 Terminated

2 enrolled

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia